Senior Counsel, Intellectual Property
- Employer
- Intellia Therapeutics
- Location
- Cambridge, MA
- Start date
- Oct 31, 2022
View more
- Discipline
- Regulatory, Legal/Compliance
- Required Education
- Doctorate/PHD/MD
- Position Type
- Full time
- Hotbed
- Genetown, Best Places to Work
Job Details
Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We wantall ofour people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
How you will Achieve More with Intellia:
As a Senior Counsel on the Intellectual Property team, you will partner with researchers and legal professionals in the creation, management, and protection of intellectual property assets. In this role, you will be responsible for developing and implementing IP strategies to protect Intellia’s technology platforms and the application of those technologies to develop CRISPR/Cas9- based genome editing therapies. Most importantly, we seek a team member who wants to be fully integrated into every aspect of the company from research to business execution. Additional role responsibilities include but are not limited to:
Provides expert counsel and advises cross-functional stakeholders and leadership on IP matters, including IP opportunities, risks, and mitigation strategies
Help lead the development of a worldwide IP portfolio covering therapeutic applications of CRISPR-Cas9
Identify patentable inventions through regular interactions with internal R&D project teams, and work with outside counsel to draft, file, and prosecute patent applications worldwide
Conduct due diligence assessments and counsel based on those assessments, including business development, freedom-to-operate (FTO) and IP landscape assessments
Assist with challenging and defending patents in PTAB, opposition proceedings, and other forums
Develop and implement strategies to secure freedom-to-operate for Intellia
Keep abreast of changes in IP laws that affect Intellia and its business goals
Identify unmet needs and potential IP-related legal issues and proactively propose strategies to optimize outcomes and results for the company
Work closely with other attorneys and staff to ensure that Intellia’s interests are properly protected
Serve as a role model and a champion of the legal department through work ethic, attitude, interpersonal skills, and successful results
About You:
JD degreefrom an accredited law school; registered to practice at the United States Patent and Trademark Office
7+ years of relevant IP experience in house or at a major law firm
Excellent written and verbal communication skills, including the ability to communicate complex legal or scientific issues in a simple, understandable manner with colleagues of varying technical knowledge across the company
Strong collaborative skills, able to build partnerships and alliances internally and with external partners at all levels of the organization
Strong organization and time management skills with flexibility, creativity, and resourcefulness to successfully prioritize and manage multiple, competing priorities simultaneously
Meet your future team:
This role reports to the Head of IP and works with other members of the IP Team as well as with research professionals and outside counsel. The IP Team is a hardworking, highly collaborative team staffed by individuals who value and support each other. The IP team includes hybrid remote/on-site and fully remote team members, allowing for flexibility while fostering a strong sense of community within the team and with stakeholders.
There is no road map for what we are doing as leaders in the systemic delivery of in vivo CRISPR-Cas9 therapies, while offering a full spectrum approach to creating CRISPR-Cas9 therapy using our ex vivo pipeline. We thrive on charting new territory, exploring new ways to drive our programs forward. We are cultivating the culture of ONE, EXPLORE, DISRUPT, and DELIVER that continues to make Intellia such an incredible place to work.
#LI-PD1
Covid-19 Vaccination Policy: All Intellia employees, regardless of work location, must be fully vaccinated for COVID-19. This requirement includes a booster dose once eligible. Requests for exemption for medical or sincerely held religious beliefs will be considered.
EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Company
Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.
Change life stories with genome editing therapies!
Stock Symbol: NTLA
- Website
- http://intelliatx.com/
- Phone
- (857) 285-6200
- Location
-
40 Erie Street
Cambridge
Massachusetts
02139
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert